Dong, Q., Yang, X., Zhang, Y., Jing, W., Zheng, L., Liu, Y., & Qu, X. (2014). Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: A pilot study. BioMed Central.
Chicago Style CitationDong, Qian, Xiang-hong Yang, Yao Zhang, Wei Jing, Li-qiang Zheng, Yun-peng Liu, and Xiu-juan Qu. Elevated Serum CA19-9 Level Is a Promising Predictor for Poor Prognosis in Patients With Resectable Pancreatic Ductal Adenocarcinoma: A Pilot Study. BioMed Central, 2014.
MLA CitationDong, Qian, et al. Elevated Serum CA19-9 Level Is a Promising Predictor for Poor Prognosis in Patients With Resectable Pancreatic Ductal Adenocarcinoma: A Pilot Study. BioMed Central, 2014.
Warning: These citations may not always be 100% accurate.